Clinical Trial Update: Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating elacestrant with or without triptorelin in premenopausal women with luminal, hormone receptor-positive, HER2-negative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Premenopausal Breast Cancer

Drugs mentioned

• Elacestrant (elacestrant)
• Triptorelin (triptorelin)

Snippet

Sponsor: SOLTI Breast Cancer Research Group | Conditions: Breast Cancer, HER2-negative Breast Cancer | Phase 2 | Status: RECRUITING